Back

Outcome of patients with cardiogenic shock in acute myocardial infarction treated with Impella CP and a standardized protocol

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Risk stratification in acute coronary syndromes with cardiogenic shock Shock ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Marek Sramko

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

6 More presentations in this session

Presentation thumbnail
Predictive values of age shock index and age modified shock index for in-hospital mortality in patients with ST-segment elevation myocardial infarction
Miss S. Lyu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The BE-ALIVE score: predicting 30-day mortality in patients presenting with acute coronary syndromes and cardiogenic shock
Doctor A. Tindale (London, GB)
Abstract Slides Video
Presentation thumbnail
Novel risk score of mortality prediction for critical cardiogenic shock patients
Doctor M. Wang (Kaohsiung, TW)
Abstract Slides Video
Presentation thumbnail
Temporal trends in intra-aortic balloon pump use
Doctor B. Cohen (Petah Tikva, IL)
Abstract Slides Video
Presentation thumbnail
Validation of the BALLAR score for predicting 30-day mortality in patients requiring Impella monotherapy
Doctor A. Tindale (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in acute coronary syndromes with cardiogenic shock

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
The effect of treatment srategy for acute myocardial infarction complicated by cardiac shock using Impella in accordance with institutional protocol
thumbnail
Congress Presentation
Safety and mid-term outcomes of impella compared to intra-aortic balloon pumping in patients who required mechanical cardiac support
thumbnail
Congress Presentation
Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources